Daesung Microbiological Labs. Co., Ltd.

₩5,090As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:036480Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.19%)
Div yield 1.47%
ROE 1.02%
Pharmaceutical Preparations
Beta (5Y) 0.07
PE TTM 55.14
TSR TTM (29.08%)
Mkt cap ₩19.34B
ROIC (1.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩5,316
4.43%
(93.87%)
Hold 12|9|8|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
54.58
52.37
50.13
54.66
8.51%
8.29%
8.82%
9.47%
Revenue₩B
1.075
1.125
1.177
1.144
0.69%
8.25%
12.54%
11.78%
Peers (US$14.26M)
Cap (US$)
PE
14.50M
11.31x
14.32M
10.49x
Capital
TTM
5Y
10Y
Leveragex
1.286
(0.064)
(0.063)
EBIT/Intx
6.594
0.056
0.057
Own earn%
(44.63)
(255.22)
(252.59)
Sh yield%
18.92
28.86
28.96
Owners
Insiders/Inst%
3.86
75.61
Short interest%
2.68
SBC / revenue%
3.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
5–15
$1 testx
−0.1
Incr. ROIC%
9